11 Pancreatic Cancer Clinical Trials in Tampa, FL (2026)

Q: How do I join a clinical trial in Tampa?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Tampa research site will contact you.

Recruiting Pancreatic Cancer Studies in Tampa

NCT07491445Recruiting

Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

The purpose of this study is to evaluate the safety and efficacy of an investigational RAS(ON) inhibitor administered as monotherapy or in combination with chemotherapy, compared with standard of care...

Tampa, FLPHASE3900 participantsRevolution Medicines, Inc.

View Study Details

NCT07621718Recruiting

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

The purpose of this study is to evaluate the efficacy of an investigational RAS(ON) inhibitor administered in combination with chemotherapy compared to placebo in combination with chemotherapy....

Tampa, FLPHASE3670 participantsRevolution Medicines, Inc.

View Study Details

NCT02674100Recruiting

American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry

The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can prov...

Tampa, FL500 participantsUniversity of Louisville

View Study Details

NCT01954992Recruiting

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

The study is designed to assess whether glufosfamide provides additional survival benefit as compared to bolus 5-FU in patients with metastatic pancreatic cancer who have already progressed or failed ...

Tampa, FLPHASE3480 participantsEleison Pharmaceuticals LLC.

View Study Details

NCT07805954Recruiting

Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma

The purpose of this study is to evaluate the efficacy of combination therapy with two investigational RAS(ON) inhibitors (daraxonrasib and zoldonrasib) compared to chemotherapy....

Tampa, FLPHASE3400 participantsRevolution Medicines, Inc.

View Study Details

NCT07217717Recruiting

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Pancreatic Ductal Adenocarcinoma (PDAC)

This is a multi-site, open-label, non-randomized, single dose study to assess the clinical utility of \[¹⁸F\]FAPI-74 PET/CT in the detection of metastatic disease in individuals with pathologically co...

Tampa, FLPHASE3200 participantsSOFIE

View Study Details

NCT07542041Recruiting

Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens

The goal of this clinical study is to evaluate whether the NEO-Match® test, based on ARTIDIS nanomechanical profiling technology, can help predict treatment outcomes and improve clinical decision-maki...

Tampa, FLNA200 participantsARTIDIS AG

View Study Details

NCT07644559Recruiting

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer

This study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab in patients with metastatic KRAS G12D - mutated Pancreatic Cancer...

Tampa, FLPHASE2185 participantsVerastem, Inc.

View Study Details

NCT07249775Recruiting

A First-in-Human Study of FID-022 in Solid Tumor Patients

This observational study aims to (1) validate a multimodal artificial intelligence (AI) model for early detection of cancer-associated cachexia in pancreatic cancer patients and (2) assess the feasibi...

Tampa, FL120 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

NCT02843945Recruiting

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Initial study to evaluate local control and the preferred method of attachment of the CivaSheet in the setting of suspected close or positive margins at the time of surgical tumor removal....

Tampa, FLPHASE180 participantsCivaTech Oncology

View Study Details

NCT06423963Recruiting

Remote Exercise and Nutritional Prehabilitation for Pancreatic Cancer

The purpose of the study is to examine the feasibility and acceptability of an exercise and nutrition "prehabilitation" program for patients preparing for pancreatic cancer resection (removal)....

Tampa, FLNA26 participantsH. Lee Moffitt Cancer Center and Research Institute

View Study Details

About Pancreatic Cancer Clinical Trials in Tampa

Pancreatic cancer begins in the tissues of the pancreas and is often diagnosed at an advanced stage. It is one of the most challenging cancers to treat. Clinical trials are actively investigating new approaches including immunotherapy and combination regimens.

There are currently 11 pancreatic cancer clinical trials recruiting participants in Tampa, FL. These studies are seeking a combined 3,761 participants. Research is being sponsored by Revolution Medicines, Inc., University of Louisville, Eleison Pharmaceuticals LLC. and 5 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pancreatic Cancer Clinical Trials in Tampa — FAQ

Are there pancreatic cancer clinical trials in Tampa?

Yes, there are 11 pancreatic cancer clinical trials currently recruiting in Tampa, FL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tampa?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tampa research site will contact you about next steps.

Are clinical trials in Tampa free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tampa studies also compensate for your time and travel.

What pancreatic cancer treatments are being tested?

The 11 active trials in Tampa are testing new therapies including novel drugs, biologics, and treatment approaches for pancreatic cancer.

Data updated October 17, 2026 from ClinicalTrials.gov